CPRX
CPRX
US14888U1016
Catalyst Pharmaceuticals, Inc.
Loading chart...

Company Profile

-

Related stocks

VKTX
VKTX • United States
Viking Therapeutics, Inc.
28.51 USD
3.63B USD 1Y -14.3%
LEGN
LEGN • United States
Legend Biotech Corporation
18.62 USD
3.62B USD 1Y -41.9%
ACAD
ACAD • United States
ACADIA Pharmaceuticals Inc.
19.78 USD
3.39B USD 1Y -8.1%
SRRK
SRRK • United States
Scholar Rock Holding Corporatio
42.19 USD
5.14B USD 1Y +9.1%
RCUS
RCUS • United States
Arcus Biosciences, Inc.
24.41 USD
3.11B USD 1Y +58.3%
IOVA
IOVA • United States
Iovance Biotherapeutics, Inc.
14.62 USD
6.62B USD 1Y +486.3%
ERAS
ERAS • United States
Erasca, Inc.
16.03 USD
5.61B USD 1Y +536.2%
MIRM
MIRM • United States
Mirum Pharmaceuticals, Inc.
86.01 USD
5.58B USD 1Y +11.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Beta Factor
0.74
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende